In consultation: Guidance and quality standards
Showing 1 to 4 of 4
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Highly specialised technologies: NICE prioritisation board routing criteria | Methods / process manual consultation | NICE process and methods | |
| Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids in people aged 12 and over [ID6377] | Draft guidance | Technology appraisal guidance | |
| Cladribine for treating relapsing multiple sclerosis [ID6263] | Draft guidance | Technology appraisal guidance | |
| Robot-assisted surgery for orthopaedic procedures: early value assessment | Draft guidance | Health technology evaluation |